✦ LIBER ✦

Oral insulin administration and residual (β-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial

✍ Scribed by Lucy Chaillous; Hervé Lefèvre; Charles Thivolet; Christian Boitard; Najiba Lahlou; Catherine Atlan-Gepner; Béatrice Bouhanick; Agnès Mogenet; Marc Nicolino; Jean-Claude Carel; Pierre Lecomte; Richard Maréchaud; Pierre Bougnères; Bernard Charbonnel; Pierre Saï

Book ID: 117275826
Publisher: The Lancet
Year: 2000
Tongue: English
Weight: 97 KB
Volume: 356
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(00)02579-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

No effect of oral insulin on residual be

No effect of oral insulin on residual beta-cell function in recent-onset Type I diabetes (the IMDIAB VII)

✍ P. Pozzilli; D. Pitocco; N. Visalli; M. G. Cavallo; R. Buzzetti; A. Crinò; S. Sp 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 79 KB

Effect of intensive insulin therapy on β

Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial

✍ Jianping Weng; Yanbing Li; Wen Xu; Lixin Shi; Qiao Zhang; Dalong Zhu; Yun Hu; Zh 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 160 KB

HLA in relation to retinopathy, residual

HLA in relation to retinopathy, residual β-cell function and age at onset in Type 1 (insulin-dependent) diabetic patients

✍ R. Danielsen 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 116 KB

The effects of calcitriol and nicotinami

The effects of calcitriol and nicotinamide on residual pancreatic β-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI)

✍ D. Pitocco; A. Crinò; E. Di Stasio; S. Manfrini; C. Guglielmi; S. Spera; G. Bere 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

β-cell function in new-onset type 1 diab

β-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial

✍ Itamar Raz; Dana Elias; Ann Avron; Merana Tamir; Muriel Metzger; Irun R Cohen 📂 Article 📅 2001 🏛 The Lancet 🌐 English ⚖ 86 KB

Four-year metabolic outcome of a randomi

Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass

✍ B. Keymeulen; M. Walter; C. Mathieu; L. Kaufman; F. Gorus; R. Hilbrands; E. Vand 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 216 KB